SCHEMBL7083256

SCHEMBL7083256

CCCCN(Cc1cccc(C(=N)NO)c1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 9/20 0.55
HDAC6 Q9UBN7 9/20 0.55
GRIN2D O15399 1/20 0.52
GRIN3B O60391 1/20 0.52
GRIN1 Q05586 1/20 0.52
GRIN2A Q12879 1/20 0.52
GRIN2B Q13224 1/20 0.52
GRIN2C Q14957 1/20 0.52
GRIN3A Q8TCU5 1/20 0.52
HDAC3 O15379 4/20 0.48
HDAC2 Q92769 4/20 0.48
HDAC4 P56524 2/20 0.48
HDAC7 Q8WUI4 2/20 0.48
HDAC8 Q9BY41 2/20 0.48
HDAC9 Q9UKV0 2/20 0.48
HDAC5 Q9UQL6 2/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
NCOR2 Q9Y618 1/20 0.48
PKM P14618 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7086989 0.96 HDAC1 (0.51) HDAC1HDAC6GRIN2DGRIN3BGRIN1
SCHEMBL7087197 0.93 HDAC1 (0.53) HDAC1HDAC6GRIN2DGRIN3BGRIN1
SCHEMBL7083688 0.87 PPARG (0.52) HDAC1HDAC6GRIN2DGRIN3BGRIN1
SCHEMBL7087160 0.86 MEP1B (0.53) HDAC1HDAC6GRIN2DGRIN3BGRIN1
SCHEMBL7083982 0.85 GRIN2D (0.61) HDAC1HDAC6GRIN2DGRIN3BGRIN1
SCHEMBL17766326 0.83 GRIN2D (0.63) HDAC1HDAC6GRIN2DGRIN3BGRIN1
SCHEMBL7083364 0.81 GRIN2D (0.51) HDAC1HDAC6GRIN2DGRIN3BGRIN1
SCHEMBL7090135 0.81 GRIN2D (0.56) HDAC1HDAC6GRIN2DGRIN3BGRIN1
SCHEMBL7087183 0.79 MEN1 (0.54) HDAC1HDAC6MEP1BMEP1A
SCHEMBL23588058 0.79 SPHK2 (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030199698-A1 Carbamic acid esters as inhibitors of factor xa MERCK PATENT GMBH (DE) 2003-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199698-A1 Carbamic acid esters as inhibitors of factor xa F11, F12, F13A1 HDAC1 159/4885HDAC6 1923/4885GRIN2D 3815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.